venture capital / classical biotechnology business model / pharmaceuticals / biotechnology / pharmaceutical industry / classical biotechnology model / specific technologies / health care services / classical biotechnology / key components like networks / health biotechnology / overall health care systems / health biotechnology functions / industries developing health biotechnology / open source software / reasonable quality services / pharmaceutical firms / diagnostic equipment / biotechnology sectoral system / /
MedicalCondition
disease / diabetes / diseases / avian flu / /
MedicalTreatment
surgery / /
Organization
Industrial Management School of Business / Business / Economics and Law Göteborg University Sweden / OECD / /
Person
David Sawaya / Anthony Arundel / / /
Position
model / scientific discoveries / second institutional driver / first institutional driver / International Futures Programme Executive / Executive / classical biotechnology model / scientific discoveries / institutional driver / /
MULTI-DISCIPLINARY ISSUES INTERNATIONAL FUTURES PROGRAMME OECD International Futures Project on “The Bioeconomy to 2030: Designing a Policy Agenda”